CHOROIDAL NEOVASCULARIZATION
Clinical trials for CHOROIDAL NEOVASCULARIZATION explained in plain language.
Never miss a new study
Get alerted when new CHOROIDAL NEOVASCULARIZATION trials appear
Sign up with your email to follow new studies for CHOROIDAL NEOVASCULARIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug tiespectus takes on aflibercept in major wet AMD trial
Disease control Recruiting nowThis study tests a new medicine called tiespectus (EYE201) for wet age-related macular degeneration, a leading cause of vision loss. About 960 people will receive either tiespectus or the standard treatment aflibercept via eye injections. The goal is to see if tiespectus can impr…
Matched conditions: CHOROIDAL NEOVASCULARIZATION
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New eye drug could rival standard treatment for blinding disease
Disease control Recruiting nowThis study tests a new medicine called tiespectus (EYE201) for wet age-related macular degeneration, a leading cause of vision loss. About 960 people will receive either tiespectus or the standard treatment aflibercept via eye injections. The goal is to see if tiespectus works as…
Matched conditions: CHOROIDAL NEOVASCULARIZATION
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC